This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Boehringer Mannheim Gmbh. Active years: 1995-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1996
Title: Innovations by Charles F Walter in Medicinal Chemistry
Introduction
Charles F Walter, an accomplished inventor based in Carmel, IN, has made significant contributions to the field of medicinal chemistry. With a total of two patents to his name, Walter's work focuses on novel derivatives that enhance the efficacy and safety of existing therapeutic agents.
Latest Patents
Walter's latest innovations include two pivotal patents. The first patent discloses novel derivatives of procainamide and N-acetylprocainamide (NAPA), specifically the piperidine analogs and conjugates. These derivatives have unique structural formulas designed to improve pharmacological properties. The second patent focuses on maleimide adduct conjugates of procainamide and NAPA, which also present innovative structural formulations. These advancements highlight Walter's expertise in developing new therapeutic modalities for clinical application.
Career Highlights
Charles F Walter is associated with Boehringer Mannheim GmbH, a company that specializes in biochemical and pharmaceutical innovations. His work within this organization showcases his commitment to research and development in the field of medicinal chemistry, contributing to the advancement of new drug therapies.
Collaborations
Throughout his career, Walter has collaborated with notable coworkers such as Gerald F Sigler and Todd P Glancy. These partnerships exemplify the collaborative spirit essential for conducting cutting-edge research in the pharmaceutical industry.
Conclusion
Charles F Walter's innovative work in the development of novel chemical derivatives positions him as a key figure in medicinal chemistry. His patents not only reflect his technical expertise but also his dedication to improving therapeutic options for patients. Through his contributions, Walter continues to make strides in the ever-evolving landscape of drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
